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**Value of the data**•These data can be used for defining the scientific quality of the most relevant published series of patients undergoing catheter ablation for FVT.•These data also provide useful information for guiding the ablation strategy for FVT, by defining the timing of the pre-Purkinje potentials at the successful ablation site and the incidence of fascicular block after ablation.

1. Data {#s0005}
=======

The data presented in this article are supplementary material to our systematic review on catheter ablation for FVT [@bib1].

[Table S1](#s0035){ref-type="sec"} shows the results of the quality assessment for case series studies using the National Heart, Lung, and Blood Institute scale [@bib2].

[Table S2](#s0035){ref-type="sec"} shows supplementary procedural data on catheter ablation for FVT. We report the earliest interval between pre-Purkinje potentials and QRS during tachycardia at the ablation site. Furthermore, we provide data regarding incidence of fascicular block after catheter ablation.

2. Experimental design, materials and methods {#s0010}
=============================================

We performed a systematic electronic search of the published studies including patients who underwent catheter ablation for FVT [@bib1]. Thirty-eight studies were selected. Quality assessment was performed for each study by two independent reviewers (AC and RP) using the National Heart, Lung, and Blood Institute Quality Assessment Tool for Case Series Studies [@bib2]. The third author (AWC) intervened to resolve disputes in case of disagreement of the two principal reviewers regarding the classification of a study. The procedural data from each study were also analysed, with a focus on the interval between pre-Purkinje potentials and QRS complex during tachycardia at the ablation site and the incidence of fascicular block after catheter ablation.

Transparency document. Supplementary material {#s0025}
=============================================

Supplementary material.

Appendix A. Supplementary material {#s0035}
==================================

Supplementary material.
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